Professor, School of Materials Science and Engineering, Harbin Institute of Technology (Shenzhen)

One of the National High-quality Overseas Professionals, Guangdong Pearl River Talent Program, Shenzhen Peacock Talent Program, and Global Top 1% Scientists

He has presided over and participated in a number of research projects such as the Natural Science Foundation of China, the Guangdong Provincial Science and Technology Innovation Strategy Special Project, the Shenzhen Science and Technology Commission Discipline Layout Project, the Shenzhen Peacock Talent Team, the Shenzhen Nobel Scientist Laboratory Project, and the like.

A total of over 190 SCI papers were published, with more than 5,000 citations and an h-index of 45; more than 50 patents were applied for and more than 10 were authorized.

He founded Shenzhen Shinesky Biological Technology Co., Ltd, which systematically applied the Nobel Prize-winning supramolecular technology to the pan-health field twice, and built the world’s first production line for bio-based supramolecular materials with an annual capacity of 1,000 tons.

Associate Professor, Zhejiang University of Technology

Founder and CEO of Hangzhou Jiajiale

Graduated from China Agricultural University with his bachelor's, master's, and doctorate degrees

Applied for 114 invention patents, with 38 patents authorized

Published 36 SCI papers and one monograph in a foreign language.

Set up six synthetic biological production lines with an annual output value of over 500 million yuan.

Glycerol Glucose, developed by him, won the first 2021 PCHi Fountain Innovation Nomination Award and the Ringier Technology Innovation Award.

Professor and Doctoral Supervisor, School of Preclinical Medical Sciences, Chongqing Medical University, China

Member of the Chinese Society for Cell Biology

PhD in Biochemistry and Molecular Biology

Published a number of papers in international and domestic high-level academic journals (incl. Biomaterials, CR, and NPJ)

Natural reviewer for internationally recognized journals such as Biomaterials, RSC, etc.

Winner of the second prize of National Science and Technology Progress

The currently the director of Shanghai Qisheng Biomaterials Technology Research Institute

Visiting professor at the Yantai University

Member of the American Society for Biomaterials

Member of Chinese Society of Biomaterials and Chinese Society of Biomedical Engineering

China's first hyaluronic acid class III medical device winner

A total of over 200 academic papers were published, edited more than 10 academic monographs, and applied for 36 related patents

Ph.D. Candidate, Harbin Institute of Technology (Shenzhen);

Main research interests: Design, synthesis, and application of bio-based supramolecules, delivery of peptide-protein drugs; complete research experience in molecular biology such as supramolecular self-assembly, anti-aging, DNA damage response, and cellular signaling pathways; with 6 SCI papers published and 5 patents applied;

6+ years of R&D experience in this field

Master’s degree from Guangdong Pharmaceutical University;

Main research interests: Research and development of new drug delivery systems (incl. stem cells, exosomes, liposomes, etc.), design and preparation of implantable bio-materials, multi-pathway delivery of small molecules and gene therapy, and activity studies of poly-peptide proteins; 2 published SCI papers and 2 patented projects;

3+ years of R&D experience in this field

Master’s degree from Wuyi University;

Main research interests: Rene editing, cell culture, and in vitro efficacy validation of self-assembled short peptides; familiarity with the use of gene editing tools such as TALEN and CRISPR; extensive experience in gene detection, gene target site screening, cell culture, cellular drug delivery, micro-injection, etc. One published SCI paper;

3+ years of R&D experience in this field

Central South University of Forestry and Technology;

Main research interests: Design and synthesis of small-molecule anti-tumor targeting drugs and their applications in the pharmaceutical field;

He has many years of experience in small molecule drug synthesis, isolation, and purification; is familiar with ADC and PDC antibody coupling technology; and is proficient in qualitative and quantitative detection in drug development. He has published four SCI papers and applied for three patents.

10+ years of R&D experience in this field